Big Picture Bio raises $2.9M
Big Picture Bio announced a Pre-Seed round of $2.9M on 18 September 2026. The company operates in HealthTech and is based in United Kingdom. It was founded by Kerstin Papenfuss, CEO & Co-founder. Announced 3 days ago.
Founder
Kerstin Papenfuss
CEO & Co-founder, Big Picture Bio
Outreach angles
- -Papenfuss previously led the therapeutics team at Deep Science Ventures, where she helped found 12 companies before launching Big Picture Bio.
- -She partnered with longtime collaborator Mark Hammond, who scaled Deep Science Ventures' portfolio past 1.16 billion euros, after seven years working together.
- -The 2.55 million euro pre-seed round lets Big Picture Bio move its AI-designed cancer drug combinations from computational models into laboratory testing.
Signals
Pre-SeedHealthcareDeep TechAI-NativeSecond-Time Founder
Round details
Company: Big Picture Bio
Domain: bigpicturebio.com
Amount: $2.9M
Stage: Pre-Seed
Industry: HealthTech
Country: United Kingdom
Announced: 18 September 2026
Other HealthTech raises
Recently funded in United Kingdom